Action AARTIDRUGS AARTI DRUGS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Aarti Drugs Limited

Actions

AARTIDRUGS

INE767A01016

Marché Fermé - Bombay S.E.
Autres places de cotation
 12:00:49 26/04/2024 		Varia. 5j. Varia. 1 janv.
503,8 INR +0,67 % Graphique intraday de Aarti Drugs Limited +1,51 % +3,01 %
29/03 Aarti Drugs Limited annonce la cessation des fonctions de ses dirigeants CI
31/01 Aarti Drugs commence à fabriquer des produits dermatologiques sur son site de Tarapur, en Inde MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Aarti Drugs Limited Announces Executive Cessation
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.
Aarti Drugs Limited's Equity Buyback announced on July 21, 2023, has closed with 665,000 shares, representing 0.72% for INR 598.5 million.
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Aarti Drugs Limited authorizes a Buyback Plan.
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.
Aarti Drugs' Consolidated Profit Climbs in Fiscal Q4
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Aarti Drugs' Consolidated Net Profit Declines in Fiscal Q3
Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2022-23
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Aarti Drugs : Loss of Share Certificates
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action AARTIDRUGS
  4. Actualités Aarti Drugs Limited
  5. Autres langues